Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
31°
Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Jasper Therapeutics, Inc. - Class A Common Stock
(NQ:
JSPR
)
22.50
+0.79 (+3.64%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Jasper Therapeutics, Inc. - Class A Common Stock
< Previous
1
2
3
4
Next >
Why Is Chronic Disease-Focused Jasper Therapeutics Stock Trading Higher On Monday?
October 14, 2024
Jasper Therapeutics' SPOTLIGHT study reports 93% clinical response in cold urticaria and symptomatic dermographism. The 120mg dose showed 83% complete response and no severe adverse events. Full data...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
October 14, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
October 09, 2024
Via
Benzinga
JSPR Stock Earnings: Jasper Therapeutics Beats EPS for Q2 2024
August 13, 2024
JSPR stock results show that Jasper Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
JSPR Stock Earnings: Jasper Therapeutics Beats EPS for Q1 2024
May 14, 2024
JSPR stock results show that Jasper Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
JSPR Stock Earnings: Jasper Therapeutics Beats EPS for Q4 2023
March 06, 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Via
InvestorPlace
Jasper Therapeutics: Q3 Earnings Insights
November 09, 2023
Via
Benzinga
Where Jasper Therapeutics Stands With Analysts
May 15, 2023
Via
Benzinga
Jasper Therapeutics: Q1 Earnings Insights
May 12, 2023
Via
Benzinga
Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
June 20, 2024
Via
Benzinga
Spirit Airlines Posts Weak Results, Joins Integra LifeSciences, Bowlero And Other Big Stocks Moving Lower On Monday
May 06, 2024
Via
Benzinga
7 Analysts Have This to Say About Jasper Therapeutics
February 27, 2023
Via
Benzinga
Over $15M Bet On Aon? Check Out These 3 Stocks Insiders Are Buying
February 12, 2024
Although U.S. stocks closed mixed on Friday, there were a few notable insider trades.
Via
Benzinga
Why FMC Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
February 06, 2024
Shares of FMC Corporation (NYSE: FMC) fell sharply during Tuesday’s session after the company reported worse-than-expected fourth-quarter results.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
January 18, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
January 17, 2024
Via
Benzinga
Jasper Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 18, 2023
From
Jasper Therapeutics, Inc.
Via
GlobeNewswire
Jasper Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
November 09, 2023
From
Jasper Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
September 11, 2023
Via
Benzinga
Jasper Therapeutics Reports Second Quarter 2023 Financial Results and Provides a Business Update
August 11, 2023
From
Jasper Therapeutics, Inc.
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For August 11, 2023
August 11, 2023
Via
Benzinga
Gilead Boosts Biotech Footprint With Stakes In AlloVir And Arcus
July 13, 2023
Regulatory filings show Gilead Sciences' purchase of shares in AlloVir and Arcus. Strategic investments in the biotech sector are fairly common to boost growth.
Via
MarketBeat
Topics
Retirement
Exposures
Pension
Jasper Therapeutics, Inc. (NASDAQ: JSPR) Featured in Coverage of the Inaugural EF Hutton Global Conference
May 02, 2023
Via
Investor Brand Network
$4M Bet On Jasper Therapeutics? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
April 12, 2023
The Dow Jones closed higher by around 100 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
Why iMedia Brands Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket
April 12, 2023
Gainers HeartCore Enterprises, Inc. (NASDAQ: HTCR) jumped 119.6% to $1.96 in pre-market trading. HeartCore forged an agreement with rYojbaba Inc for its tenth Go IPO consulting service win.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
April 12, 2023
Pre-market stock movers are a hot topic on Wednesday as we dive into all of the latest news affecting markets this morning.
Via
InvestorPlace
Jasper Therapeutics Touts Encouraging Data From Briquilimab Conditioning In Inherited Bone Marrow Disorder
February 17, 2023
Via
Benzinga
Why Nogin Shares Are Trading Higher By Around 77%; Here Are 20 Stocks Moving Premarket
February 17, 2023
Gainers Ibio Inc (NYSE: IBIO) shares rose 162.6% to $1.97 in pre-market trading after dropping around 12% on Thursday. JMP Securities, on Thursday, downgraded iBio from Market Outperform to Market...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
February 17, 2023
We're starting off the final trading day of the week with a look at the biggest pre-market stock movers worth watching on Friday!
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
February 16, 2023
Via
Benzinga
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.